Search for: "Abbott v. Abbott" Results 1641 - 1660 of 2,325
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Apr 2018, 4:36 am by Edith Roberts
At Talking Points Memo, Richard Hasen argues that when it decides Abbott v. [read post]
23 Nov 2014, 4:06 pm by INFORRM
Media Law in Other Jurisdictions Australia In the case of Setka v Abbott [2014] VSCA 287, the Court of Appeal of Victoria dismissed an appeal by trade union leader John Setka in his libel action against the Australian Prime Minister, Tony Abbott. [read post]
25 Aug 2014, 8:57 am
"Her reasons were as follows:The very act of submitting an ANDA is an act of infringement (Teva v Novartis (2007))Infringement suits under Section 271(e)(2) should not be treated differently then patent infringement suits under Section 271(a) (Abbott Labs v Torpharm (2007))In Teva the Federal Circuit considered whether Teva could pursue its claims for declarations of non-infringement in respect of four of Novartis's unasserted Orange Book… [read post]
7 Jul 2010, 5:14 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/   Highlights this week included: Biotechnology patents: Court of Justice of the EU decides against patent theory of Monsanto: Monsanto v Cefetra & Ors (BLOG@IP::JUR) (EPLAW) (IPKat) Prilosec / Losec (Omeprazole) - EU: General Court largely upholds European Commission decision in AstraZeneca v Commission (EPLAW) (IPKat)   General An… [read post]
6 Jul 2010, 6:03 pm by Duncan
  Highlights this week included: Biotechnology patents: Court of Justice of the EU decides against patent theory of Monsanto: Monsanto v Cefetra & Ors (BLOG@IP::JUR) (EPLAW) (IPKat) Prilosec / Losec (Omeprazole) – EU: General Court largely upholds European Commission decision in AstraZeneca v Commission (EPLAW) (IPKat)   General An overview of the ‘Health Impact Fund’ model for accessible medicines (Spicy IP) Pharma pay-and-procure symposium (IP… [read post]
6 Oct 2010, 4:22 am by Kelly
(profitability through simplicity) US: Yeda Appeals Board decision favoring Abbott in TBP-II interference (Holman’s Biotech IP Blog) US: Jury finds Scruggs wilfully infringed Monsanto patents, awards at least $9 million in damages (Holman’s Biotech IP Blog) US: Marcy Kaptur’s bill to create a compulsory license for patented seeds: the Seed Availability and Competition Act of 2009 (KEI) US: Glaxosmithkline Biologicals seeks review of BPAI decision concerning isolated… [read post]
19 Apr 2016, 3:27 am by Amy Howe
Yesterday the Court heard oral arguments in United States v. [read post]